Odyssey Therapeutics (ODTX) vs Vor Biopharma (VOR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Vor Biopharma is the larger company by market cap ($1.11 billion vs $868.9 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ODTX | VOR |
|---|---|---|
| Share price | $18.08 | $18.78 |
| Market cap | $868.90M | $1.11B |
| 1-day change | -0.28% | +2.57% |
| YTD return | — | +43.58% |
| 1-year return | — | -44.44% |
| 5-year return | — | -93.93% |
| P/E ratio (TTM) | — | 0.10 |
| EPS (TTM) | $-7.53 | $180.18 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $29.05 | $33.50 |
| 52-week low | $15.10 | $6.50 |
| Distance from 52-week high | -37.76% | -43.94% |
| Average volume | 271.02K | 999.37K |
| Shares outstanding | 48.06M | 59.16M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ODTX vs VOR FAQ
Which is bigger, Odyssey Therapeutics or Vor Biopharma?
Vor Biopharma (VOR) is larger, with a market capitalization of $1.11B compared with $868.90M for Odyssey Therapeutics (ODTX).
Are Odyssey Therapeutics and Vor Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.